James B. Tananbaum Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for James B. Tananbaum.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of James B. Tananbaum. James B. Tananbaum is a in Kinnate Biopharma Inc. ($KNTE) and a Director in Gemini Therapeutics, Inc. /DE ($FSDC).

Address: 3052 PACIFIC AVENUE SAN FRANCISCO 94115 CA

Companies in which James B. Tananbaum is an Insider

Gemini Therapeutics, Inc. /DE

Trading Symbol: FSDC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James B. Tananbaum: Director
Holdings: 1,500,000 shares
Latest Transaction: Feb 09 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Kinnate Biopharma Inc.

Trading Symbol: KNTE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James B. Tananbaum:
Holdings: 9,671,643 shares
Latest Transaction: Dec 09 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of James B. Tananbaum

Sentiment: All, FSDC, KNTE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 09 2021FSDCGemini Therapeutic ...Tananbaum James B.DirectorOption ExerciseC0.002,928,75000
Feb 09 2021FSDCGemini Therapeutic ...Tananbaum James B.DirectorBuyC0.002,928,75002,928,7500 to 2.9 M
Feb 09 2021FSDCGemini Therapeutic ...Tananbaum James B.DirectorGrantA10.001,500,00015,000,0001,500,0000 to 1.5 M
Dec 09 2020KNTEKinnate Biopharma ...Tananbaum James B.Option ExerciseC0.0048,37600
Dec 09 2020KNTEKinnate Biopharma ...Tananbaum James B.Option ExerciseC0.00145,12800
Dec 09 2020KNTEKinnate Biopharma ...Tananbaum James B.Option ExerciseC0.00157,22200
Dec 09 2020KNTEKinnate Biopharma ...Tananbaum James B.Option ExerciseC0.0018,64100

View all James B. Tananbaum insider transactions.

What is the IPO and How Does a Company Go Public?

IPO stands for Initial Public Offering. An IPO is done when a privately owned company wants to sell a portion of it to public investors. Through this process the company is transformed from a privately owned to a company owned by public investors. More ...

What Is Illegal Insider Trading?

Illegal Insider trading occurs when a trade has been influenced by the possession of "material" and "non-public" information about the security. Because such information is not available to other investors, a person using it is trying to gain an unfair advantage over others. More ...

What Is a Rule 10b5-1 Plan?

Rule 10b5 is one of the most important acts put forth by the SEC. It prohibits fraud, misrepresentation, and deceit in the sale and purchase of securities on national exchanges. More ...

Contact us | Follow us on Twitter